Qube Research & Technologies (QRT)’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-48,038
Closed -$7.94M 3052
2021
Q2
$7.94M Buy
48,038
+46,359
+2,761% +$7.74M 0.09% 267
2021
Q1
$257K Buy
+1,679
New +$228K ﹤0.01% 1533
2020
Q4
Sell
-7,112
Closed -$721K 2341
2020
Q3
$721K Sell
7,112
-8,029
-53% -$819K 0.01% 903
2020
Q2
$1.47M Buy
+15,141
New +$1.41M 0.02% 748
2019
Q4
Sell
-2,696
Closed -$268K 1607
2019
Q3
$268K Buy
+2,696
New +$268K 0.18% 179
2018
Q4
Sell
-2,090
Closed -$230K 996
2018
Q3
$230K Buy
2,090
+1,967
+1,599% +$205K 0.03% 455
2018
Q2
$11K Buy
+123
New +$10.6K 0.01% 757

Other funds holding PRAH

Qube Research & Technologies (QRT)'s PRAH Position: Q3 2021 in Review

Qube Research & Technologies (QRT) sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 48,038 shares — an estimated $7.94M sold.

Qube Research & Technologies (QRT) first reported a position in PRAH in Q2 2018 and held it in 7 quarters. The position peaked at $7.94M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • Qube Research & Technologies (QRT) reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 48,038 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $7.94M.
  • Qube Research & Technologies (QRT) first reported a position in PRA Health Sciences, Inc. in Q2 2018 and held it in 7 quarters.
  • Qube Research & Technologies (QRT)'s PRA Health Sciences, Inc. position peaked at $7.94M in Q2 2021.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2021, filed 12 Nov 2021.